Compare CNTN & FINW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CNTN | FINW |
|---|---|---|
| Founded | 2017 | 1999 |
| Country | United States | United States |
| Employees | 12 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Commercial Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 185.3M | 194.4M |
| IPO Year | 2022 | 2021 |
| Metric | CNTN | FINW |
|---|---|---|
| Price | $2.03 | $13.75 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 677.0K | 34.4K |
| Earning Date | 05-13-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 21.51 |
| EPS | N/A | ★ 0.20 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $160.48 |
| Revenue Next Year | N/A | $35.27 |
| P/E Ratio | ★ N/A | $68.85 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.92 | $12.82 |
| 52 Week High | $5.27 | $22.49 |
| Indicator | CNTN | FINW |
|---|---|---|
| Relative Strength Index (RSI) | 37.11 | 46.76 |
| Support Level | N/A | $13.72 |
| Resistance Level | $3.80 | $14.70 |
| Average True Range (ATR) | 0.17 | 0.64 |
| MACD | -0.02 | -0.02 |
| Stochastic Oscillator | 21.74 | 53.52 |
Canton Strategic Holdings Inc is engaged in activities related to Canton Network, including the use of Canton Coin, to support blockchain-based infrastructure and the digitization of financial market processes. The company also operates a validator node on the Canton Network to facilitate transaction validation and network operations. It also operates a clinical-stage biotech research and development arm. Its flagship clinical asset, GV104, is being developed for a specific indication for respiratory and/or nervous system depression in military personnel and chemical incident responders. The expanded pipeline includes other indications for GV104 and GV023, an approach to autoimmune diseases as well as an early-stage multispecific biologic platform.
FinWise Bancorp is an independent bank that provides a full range of banking services to individual and commercial customers. The bank's primary source of revenue is from loans, including Small Business Administration, commercial, commercial real estate, residential real estate, and consumer. The Bank has also established Strategic Programs with various third-party loan origination platforms that use technology to streamline the origination of unsecured consumer and secured or unsecured business loans to borrowers within certain approved credit profiles.